Immutep Limited

Ticker IMMP

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

11-50 Employees
Based in Sydney, Australia

Immutep is a globally active biotechnology company, listed on the Australian Stock Exchange and on the NASDAQ Global Market in the US. As a leader in personalized bio-therapeutic products for cancer, Immutep is dedicated to leveraging its current technology and expertise to develop innovative treatment options for patients and maximize value to shareholders.

REPORT RATINGS

4.8 / 5.0 (132)

Immutep Limited reports have an aggregate usefulness score of 4.8 based on 132 reviews.

Immutep Limited